First Patients Registered Into OncoBeta's International Registry For Non-Melanoma Skin Cancer Treatments |
February 15, 2022 | February 2022 Bond Updates |
MUNICH, Feb. 15, 2022 /PRNewswire/ -- OncoBeta® GmbH is pleased to announce that the first patients have registered into the world-first International Registry that is capturing data-driven treatment results for NMSC treatments. The first-of-its kind International Registry was launched by... |
View more at: https://www.prnewswire.com:443/news-releases/first-patients-registered-into-oncobetas-international-registry-for-non-melanoma-skin-cancer-treatments-301482155.html |
Related News |
|